| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.5 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.031 | 0.5 |